The Human Medicines Regulations 2012 – …

The Human Medicines Regulations 2012 – description of each Part This document provides a brief overview of each Part of the Human Medicines Regulations 2012 …

  Human, Regulations, Descriptions, Medicine, 2012, Human medicines regulations 2012, Human medicines regulations 2012 description of

FULTIUM -D 800 IU CAPSULES - GOV.UK

Vitamin D deficiency, with levels of 25(OH)D below 25nmol/L (10ng/ml), could result in the disease rickets (or osteomalacia). The disease resulting as a deficiency is considered to be due to malabsorption

  Deficiency, Capsule, Vitamin, Fultium d 800 iu capsules, Fultium, Vitamin d deficiency

GLYCOPYRRONIUM BROMIDE 0.2MG/ML …

UKPAR Glycopyrronium Bromide 0.2 mg/ml Solution for Injection PL 00156/0115 1 GLYCOPYRRONIUM BROMIDE 0.2MG/ML SOLUTION FOR INJECTION (PL 00156/0115)

  Solutions, Injection, 0115, Solution for injection pl 00156, 00156, Solution for injection, Pl 00156

PL 00010/0643 - GOV.UK

UKPAR Canesten HC Cream PL 00010/0643 6 All excipients comply with their respective European Pharmacopoeia monographs, except triceteareth-4-

  Excipients, 3460, Pl 00010 0643, 00010

Public Assessment Report UKPAR Canesten Combi …

This is a summary of the Public Assessment Report (PAR) for Canesten Combi Pessary & External Cream 500mg / 2% w/w pessary & cream (PL 00010/0653).

DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1 g ...

PAR Ampicillin/Sulbactam 1 g/0.5 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure

  Solutions

Public Assessment Report Mutual Recognition …

PAR Sayana 104mg/0.65ml Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104MG/0.65ML SUSPENSION FOR INJECTION

  Assessment, Report, Public, Procedures, Mutual, Recognition, Public assessment report mutual recognition, Public assessment report mutual recognition procedure

Cefixime 400 mg Film-coated Tablets, PL 22805 …

MHRA PAR; CEFIXIME 400 MG FILM-COATED TABLETS, PL 22805/0032-3 2 Lay summary The Medicines and Healthcare products Regulatory Agency …

  Cefixime

Public Assessment Report Decentralised Procedure …

Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC

  Assessment, Report, Public, Procedures, Public assessment report decentralised procedure, Decentralised

Perindopril/Indapamide 2mg/0.625mg and …

UKPAR Perindopril/Indapamide 2mg/0.625 and 4mg/1.25mg Tablets PL 20092/0058-9 2 Perindopril/Indapamide 2mg/0.625mg and 4mg/1.25mg Tablets PL 20092/0058-9

  Perindopril, Perindopril indapamide, Indapamide

ランソプラゾールOD錠15mg「日医工」

品 名 ランソプラゾールod錠15mg 制作日 mc 2017.10.06 e 本コード 校 作業者印 ac 仮コード 0140s1006201 初校 原田 色 調 トラップ （ ） ...

  15mg

日本薬局方 ランソプラゾール腸溶性口腔内崩壊錠 …

20171004osxsv 17100108-01 20742020012 L P 15 LP 15 L 30 LP 販 売 名 ランソプラゾールOD錠15mg「DK」 ランソプラゾールOD錠30mg「DK」

  15mg

Representative LD50 Values - University of New …

-Tityustoxin (Tityus spp.) 0.009CNS K+ channel blocker severe hypertension, pulmonary edema, cor pulmonae. Unnamed -neurotoxin (Oxyuranus scutellatus) 0.009Non-competitive inhibitor of nACh receptor paralysis, respiratory

  Value, Representative, Representative ld50 values, Ld50

Package leaflet: Information for the user - Medicines

Page 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.

Package leaflet: Information for the user …

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.